CHS-1701

pegfilgrastim biosimilar · Coherus Oncology, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CHS-1701, covering 2016-01-07 to 2016-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta [Phase 1]